✦ LIBER ✦

S5-03-03 Treatment of mild cognitive impairment: dilemmas and opportunities

✍ Scribed by Vesna Jelic

Book ID: 117412878
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 159 KB
Volume: 25
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(04)80311-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S5-02-03: Diagnosis of mild cognitive im

S5-02-03: Diagnosis of mild cognitive impairment in research and clinical settings

✍ Ranjan Duara 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

S3-03-05 FMRI in mild cognitive impairme

S3-03-05 FMRI in mild cognitive impairment and Alzheimer's disease

✍ Serge Rombouts 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

O1-03-03: From mild cognitive impairment

O1-03-03: From mild cognitive impairment to Alzheimer’s disease: Preliminary results of a 1H-MRS longitudinal study

✍ Antonio Metastasio; Filippo Tommaso Feliziani; Patrizia Rinaldi; Mariani Elena; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

S.26.03 Potential role of amyloid imagin

S.26.03 Potential role of amyloid imaging in mild cognitive impairment in Parkinson's disease

✍ Villemagne, V.L. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Current treatment of mild cognitive impa

Current treatment of mild cognitive impairment and alzheimer’s disease

✍ David S. Knopman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 114 KB

Treatment of the mild cognitive impairme

Treatment of the mild cognitive impairment (MCI)

✍ Hervé Allain; Danièle Bentué-Ferrer; Yvette Akwa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract According to Evidence‐Based‐Medicine, any proposal for the rationale treatment of mild cognitive impairment (MCI) must be based on the results of double‐blind, randomized clinical trials (RCTs). However, since MCI at the present time does not constitute a homogeneous clinical syndrome,